SOFINDEV
2
12M
2
0.07
1
- Stages of investment
- Areas of investment
Summary
SOFINDEV appeared to be the VC, which was created in 1991. The main department of described VC is located in the Diegem. The fund was located in Europe if to be more exact in Belgium.
The standard case for the fund is to invest in rounds with 8 partakers. Despite the SOFINDEV, startups are often financed by HealthCap, Auriga Partners, Apax Partners. The meaningful sponsors for the fund in investment in the same round are Medicis Capital, Lombard Odier, Institute of Mental Health. In the next rounds fund is usually obtained by Yorkville Advisors, Pradeyrol Development.
The top activity for fund was in 2001. The increased amount of exits for fund were in 2008. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually.
Among the most successful fund investment fields, there are Hardware, Bioinformatics. Among the most popular portfolio startups of the fund, we may highlight Hybrigenics, Topcom Europe. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - France.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.07
- Investments by industry
- Bioinformatics (1)
- Biotechnology (1)
- Therapeutics (1)
- Hardware (1)
- Investments by region
-
- France (1)
- Belgium (1)
- Peak activity year
- 2005
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 26
- Group Appearance index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Hybrigenics | 01 Dec 2001 | Biotechnology, Therapeutics, Bioinformatics | Early Stage Venture | 15M | Ile-de-France, Paris, France |
Similar funds
By same location
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.